| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.
|
Cancer Discov
|
2011
|
7.65
|
|
2
|
Interleukin-6 as a therapeutic target in human ovarian cancer.
|
Clin Cancer Res
|
2011
|
2.85
|
|
3
|
Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
|
J Natl Cancer Inst
|
2006
|
2.71
|
|
4
|
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
|
BMC Cancer
|
2012
|
2.16
|
|
5
|
Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice.
|
J Clin Invest
|
2011
|
1.96
|
|
6
|
High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients.
|
Clin Cancer Res
|
2006
|
1.87
|
|
7
|
Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.
|
Am J Pathol
|
2009
|
1.81
|
|
8
|
Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.
|
Blood
|
2007
|
1.73
|
|
9
|
Isolation and characterization of progenitor-like cells from human renal proximal tubules.
|
Am J Pathol
|
2011
|
1.72
|
|
10
|
A non-functional retinoblastoma tumor suppressor (RB) pathway in premenopausal breast cancer is associated with resistance to tamoxifen.
|
Cell Cycle
|
2011
|
1.60
|
|
11
|
Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
|
Cancer Res
|
2008
|
1.59
|
|
12
|
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer.
|
J Transl Med
|
2010
|
1.51
|
|
13
|
Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up.
|
Eur J Cancer
|
2005
|
1.45
|
|
14
|
Classification of breast cancer using genetic algorithms and tissue microarrays.
|
Clin Cancer Res
|
2006
|
1.43
|
|
15
|
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis.
|
Oncogene
|
2005
|
1.42
|
|
16
|
Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
|
Diagn Pathol
|
2012
|
1.38
|
|
17
|
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.
|
Breast Cancer Res Treat
|
2013
|
1.38
|
|
18
|
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
|
Mod Pathol
|
2009
|
1.34
|
|
19
|
Expression of the cytoskeleton linker protein ezrin in human cancers.
|
Clin Exp Metastasis
|
2007
|
1.34
|
|
20
|
PKCalpha expression is a marker for breast cancer aggressiveness.
|
Mol Cancer
|
2010
|
1.34
|
|
21
|
Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
|
Diagn Pathol
|
2013
|
1.28
|
|
22
|
Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition.
|
Int J Cancer
|
2010
|
1.28
|
|
23
|
SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.
|
Am J Surg Pathol
|
2011
|
1.27
|
|
24
|
Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
|
J Clin Oncol
|
2005
|
1.23
|
|
25
|
Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study.
|
Int J Cancer
|
2011
|
1.22
|
|
26
|
Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
|
Int J Cancer
|
2006
|
1.20
|
|
27
|
Molecular profiling reveals low- and high-grade forms of primary melanoma.
|
Clin Cancer Res
|
2012
|
1.17
|
|
28
|
CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.
|
Int J Cancer
|
2007
|
1.17
|
|
29
|
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer.
|
BMC Cancer
|
2012
|
1.17
|
|
30
|
RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer.
|
Transl Oncol
|
2011
|
1.16
|
|
31
|
Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study.
|
J Transl Med
|
2011
|
1.15
|
|
32
|
Contribution of antibody-based protein profiling to the human Chromosome-centric Proteome Project (C-HPP).
|
J Proteome Res
|
2012
|
1.11
|
|
33
|
Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer.
|
Cancer Res
|
2010
|
1.11
|
|
34
|
High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer.
|
Proteomics Clin Appl
|
2011
|
1.10
|
|
35
|
Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study.
|
Biol Sex Differ
|
2012
|
1.09
|
|
36
|
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.
|
Breast Cancer Res
|
2008
|
1.08
|
|
37
|
miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro.
|
Clin Cancer Res
|
2012
|
1.04
|
|
38
|
Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer.
|
J Clin Oncol
|
2007
|
1.04
|
|
39
|
Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study.
|
Biol Sex Differ
|
2011
|
1.04
|
|
40
|
HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors.
|
Int J Cancer
|
2008
|
1.03
|
|
41
|
Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up.
|
Breast Cancer Res Treat
|
2010
|
1.03
|
|
42
|
STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer.
|
Cancer Res
|
2012
|
1.02
|
|
43
|
Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features.
|
Am J Pathol
|
2010
|
1.02
|
|
44
|
Chondroitin sulfate expression predicts poor outcome in breast cancer.
|
Int J Oncol
|
2011
|
1.01
|
|
45
|
Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition.
|
Eur J Cancer
|
2013
|
1.00
|
|
46
|
The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer.
|
J Ovarian Res
|
2012
|
1.00
|
|
47
|
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
|
Diagn Pathol
|
2011
|
1.00
|
|
48
|
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
|
Int J Cancer
|
2014
|
1.00
|
|
49
|
Wnt5a induces a tolerogenic phenotype of macrophages in sepsis and breast cancer patients.
|
J Immunol
|
2012
|
0.99
|
|
50
|
Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study.
|
BMC Cancer
|
2010
|
0.99
|
|
51
|
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.
|
BMC Cancer
|
2013
|
0.99
|
|
52
|
CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer.
|
EMBO Mol Med
|
2013
|
0.99
|
|
53
|
Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival.
|
J Ovarian Res
|
2010
|
0.98
|
|
54
|
Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer.
|
J Ovarian Res
|
2012
|
0.98
|
|
55
|
Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration.
|
PLoS One
|
2012
|
0.98
|
|
56
|
Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.
|
Mod Pathol
|
2011
|
0.97
|
|
57
|
High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.
|
Diagn Pathol
|
2012
|
0.97
|
|
58
|
Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
|
BMC Urol
|
2013
|
0.96
|
|
59
|
Polymorphisms in fatty-acid-metabolism-related genes are associated with colorectal cancer risk.
|
Carcinogenesis
|
2009
|
0.96
|
|
60
|
Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations.
|
Int J Cancer
|
2014
|
0.96
|
|
61
|
The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.
|
BMC Cancer
|
2011
|
0.95
|
|
62
|
Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer.
|
PLoS One
|
2012
|
0.95
|
|
63
|
Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.
|
Acta Oncol
|
2011
|
0.94
|
|
64
|
Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray.
|
BMC Cancer
|
2010
|
0.94
|
|
65
|
Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases.
|
Diagn Pathol
|
2013
|
0.94
|
|
66
|
Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study.
|
Biol Sex Differ
|
2013
|
0.93
|
|
67
|
Influence of anthropometric factors on tumour biological characteristics of colorectal cancer in men and women: a cohort study.
|
J Transl Med
|
2013
|
0.93
|
|
68
|
Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the Southern Swedish Lung Cancer Study.
|
Am J Clin Pathol
|
2013
|
0.93
|
|
69
|
Cysteinyl leukotriene receptor expression pattern affects migration of breast cancer cells and survival of breast cancer patients.
|
Int J Cancer
|
2010
|
0.92
|
|
70
|
The prognostic significance of tryptophanyl-tRNA synthetase in colorectal cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.92
|
|
71
|
Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.92
|
|
72
|
Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma.
|
J Transl Med
|
2014
|
0.91
|
|
73
|
Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
|
BMC Cancer
|
2010
|
0.91
|
|
74
|
Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC).
|
Breast Cancer Res Treat
|
2013
|
0.91
|
|
75
|
Plasma folate concentrations are positively associated with risk of estrogen receptor beta negative breast cancer in a Swedish nested case control study.
|
J Nutr
|
2010
|
0.90
|
|
76
|
Use of a standardized diagnostic approach improves the prognostic information of histopathologic factors in pancreatic and periampullary adenocarcinoma.
|
Diagn Pathol
|
2014
|
0.90
|
|
77
|
Breast tumours following combined hormone replacement therapy express favourable prognostic factors.
|
Int J Cancer
|
2007
|
0.89
|
|
78
|
Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro.
|
Breast Cancer Res
|
2010
|
0.88
|
|
79
|
15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma.
|
Mol Cell Proteomics
|
2008
|
0.88
|
|
80
|
Low PIP4K2B expression in human breast tumors correlates with reduced patient survival: A role for PIP4K2B in the regulation of E-cadherin expression.
|
Cancer Res
|
2013
|
0.88
|
|
81
|
p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.
|
Int J Cancer
|
2010
|
0.87
|
|
82
|
Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer.
|
Int J Cancer
|
2009
|
0.86
|
|
83
|
Molecular and genetic diversity in the metastatic process of melanoma.
|
J Pathol
|
2014
|
0.86
|
|
84
|
Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers.
|
Cancer Res
|
2005
|
0.86
|
|
85
|
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
|
Int J Cancer
|
2012
|
0.86
|
|
86
|
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen.
|
Breast Cancer Res
|
2011
|
0.86
|
|
87
|
Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression.
|
Breast Cancer Res Treat
|
2005
|
0.85
|
|
88
|
CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling.
|
Int J Colorectal Dis
|
2013
|
0.85
|
|
89
|
Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer.
|
Diagn Pathol
|
2013
|
0.85
|
|
90
|
Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study.
|
BMC Cancer
|
2013
|
0.84
|
|
91
|
Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer.
|
J Ovarian Res
|
2012
|
0.84
|
|
92
|
CRIM1 is localized to the podocyte filtration slit diaphragm of the adult human kidney.
|
Nephrol Dial Transplant
|
2009
|
0.84
|
|
93
|
Low expression of SHP-2 is associated with less favorable prostate cancer outcomes.
|
Tumour Biol
|
2012
|
0.84
|
|
94
|
Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.
|
BMC Cancer
|
2014
|
0.84
|
|
95
|
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer.
|
Breast Cancer Res
|
2014
|
0.83
|
|
96
|
Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: a population-based cohort study.
|
Biol Sex Differ
|
2012
|
0.83
|
|
97
|
The clinicopathological and gene expression patterns associated with ulceration of primary melanoma.
|
Pigment Cell Melanoma Res
|
2014
|
0.83
|
|
98
|
Anthropometric factors and ovarian cancer risk in the Malmö Diet and Cancer Study.
|
Cancer Epidemiol
|
2011
|
0.82
|
|
99
|
Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence.
|
Cancer Immunol Immunother
|
2015
|
0.82
|
|
100
|
Weight change later in life and colon and rectal cancer risk in participants in the EPIC-PANACEA study.
|
Am J Clin Nutr
|
2013
|
0.82
|
|
101
|
SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma.
|
Virchows Arch
|
2014
|
0.82
|
|
102
|
Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
|
Int J Cancer
|
2010
|
0.81
|
|
103
|
WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism.
|
Carcinogenesis
|
2013
|
0.81
|
|
104
|
Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients.
|
Radiat Oncol
|
2011
|
0.81
|
|
105
|
Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators.
|
Breast Cancer Res
|
2007
|
0.80
|
|
106
|
LRIG1 is a prognostic biomarker in non-small cell lung cancer.
|
Acta Oncol
|
2015
|
0.80
|
|
107
|
Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer.
|
J Mol Diagn
|
2011
|
0.80
|
|
108
|
Tumors with nonfunctional retinoblastoma protein are killed by reduced γ-tubulin levels.
|
J Biol Chem
|
2012
|
0.80
|
|
109
|
Protein expression profiling of formalin-fixed paraffin-embedded tissue using recombinant antibody microarrays.
|
J Proteome Res
|
2013
|
0.80
|
|
110
|
A systematic analysis of commonly used antibodies in cancer diagnostics.
|
Histopathology
|
2013
|
0.80
|
|
111
|
Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer.
|
Clin Cancer Res
|
2009
|
0.79
|
|
112
|
Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability.
|
BMC Cancer
|
2014
|
0.79
|
|
113
|
Investigation of molecular alterations of AKT-3 in triple-negative breast cancer.
|
Histopathology
|
2013
|
0.79
|
|
114
|
Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase.
|
FASEB J
|
2013
|
0.79
|
|
115
|
Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort study.
|
Int J Cancer
|
2013
|
0.79
|
|
116
|
Multiple miscarriages are associated with the risk of ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition.
|
PLoS One
|
2012
|
0.78
|
|
117
|
Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma.
|
Genes Chromosomes Cancer
|
2013
|
0.78
|
|
118
|
Molecular evolution of specific human antibody against MUC1 mucin results in improved recognition of the antigen on tumor cells.
|
Tumour Biol
|
2009
|
0.78
|
|
119
|
The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.
|
Ann Surg Oncol
|
2014
|
0.77
|
|
120
|
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
|
Springerplus
|
2013
|
0.77
|
|
121
|
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
|
Appl Immunohistochem Mol Morphol
|
2016
|
0.76
|
|
122
|
G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients.
|
Clin Cancer Res
|
2013
|
0.76
|
|
123
|
Translational database selection and multiplexed sequence capture for up front filtering of reliable breast cancer biomarker candidates.
|
PLoS One
|
2011
|
0.75
|
|
124
|
Detecting EGFR alterations in clinical specimens-pitfalls and necessities.
|
Virchows Arch
|
2013
|
0.75
|
|
125
|
Nuclear T-STAR protein expression correlates with HER2 status, hormone receptor negativity and prolonged recurrence free survival in primary breast cancer and decreased cancer cell growth in vitro.
|
PLoS One
|
2013
|
0.75
|
|
126
|
Serum concentrations of human chorionic gonadotropin beta and its association with survival in patients with colorectal cancer.
|
Cancer Biomark
|
2012
|
0.75
|